VERTEX PHARMACEUTICALS INC / MA Insider Trading Activity
Every SEC Form 4 insider transaction reported for VERTEX PHARMACEUTICALS INC / MA (VRTX), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are VRTX insiders buying or selling?
VERTEX PHARMACEUTICALS INC / MA insiders reported 5 open-market buys ($14.0M) and 525 sells ($967.5M) across 530 Form 4 filings — a net selling position of $953.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 7, 2026)
Insider sentiment
Net sellingNet insider flow of $953.5M in net selling.
Recent VRTX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale | 1.5K | $524.99 | $787.5K |
| Jul 7, 2026 | Duncan Mckechnie | EVP, Chief Commercial Officer | Sale | 1.5K | $519.00 | $799.8K |
| Jul 6, 2026 | Joy Liu | EVP and Chief Legal Officer | Sale | 828 | $502.71 | $416.2K |
| Jun 30, 2026 | Carmen Bozic | EVP and CMO | Sale | 596 | $482.50 | $287.6K |
| Jun 23, 2026 | Carmen Bozic | EVP and CMO | Sale | 1.0K | $462.17 | $471.4K |
| Jun 17, 2026 | Carmen Bozic | EVP and CMO | Sale | 4.1K | $450.00 | $1.8M |
| Jun 9, 2026 | Carmen Bozic | EVP and CMO | Sale | 1.7K | $450.00 | $785.3K |
| Jun 3, 2026 | Joy Liu | EVP and Chief Legal Officer | Sale | 828 | $439.91 | $364.2K |
| Jun 2, 2026 | Carmen Bozic | EVP and CMO | Sale | 2.0K | $450.00 | $888.3K |
| May 19, 2026 | Mark E. Bunnage | EVP, Chief Scientific Officer | Sale | 33 | $453.45 | $15.0K |
| May 19, 2026 | Carmen Bozic | EVP and CMO | Sale | 1.4K | $453.45 | $614.0K |
| May 14, 2026 | Carmen Bozic | EVP and CMO | Sale | 7.0K | $450.00 | $3.1M |
| May 5, 2026 | Joy Liu | EVP and Chief Legal Officer | Sale | 1.1K | $425.02 | $469.2K |
| May 5, 2026 | Sangeeta N. Bhatia | Director | Sale | 318 | $423.73 | $134.7K |
| Apr 3, 2026 | Joy Liu | EVP and Chief Legal Officer | Sale | 978 | $449.17 | $439.3K |
| Mar 31, 2026 | Carmen Bozic | EVP and CMO | Sale | 2.3K | $450.95 | $1.1M |
| Mar 17, 2026 | Carmen Bozic | EVP and CMO | Sale | 2.3K | $481.79 | $1.1M |
| Mar 13, 2026 | Duncan Mckechnie | EVP, Chief Commercial Officer | Sale | 2.6K | $498.42 | $1.3M |
| Mar 6, 2026 | Duncan Mckechnie | EVP, Chief Commercial Officer | Sale | 2.4K | $475.30 | $1.2M |
| Mar 4, 2026 | Joy Liu | EVP and Chief Legal Officer | Sale | 892 | $495.96 | $442.4K |
| Mar 3, 2026 | Reshma Kewalramani | CEO & President | Sale | 40.0K | $493.47 | $19.7M |
| Mar 3, 2026 | Carmen Bozic | EVP and CMO | Sale | 2.3K | $480.31 | $1.1M |
| Mar 2, 2026 | Kristen Ambrose | SVP & Chief Accounting Officer | Sale | 357 | $483.36 | $172.6K |
| Feb 26, 2026 | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale | 260 | $486.35 | $126.5K |
| Feb 26, 2026 | Amit Sachdev | EVP Chief Patient & Ext Af Off | Sale | 1.8K | $486.35 | $897.8K |
Showing the 25 most recent of 530 Form 4 filings for VERTEX PHARMACEUTICALS INC / MA.
Most active VRTX insiders
- David Altshuler67 filings
- Stuart A Arbuckle56 filings
- Michael Parini50 filings
- Amit Sachdev43 filings
- Ourania Tatsis39 filings
Ask anything about VRTX insider activity
Use Trabud's AI agent to query VERTEX PHARMACEUTICALS INC / MA's Form 4 history in plain English — "Show me VRTX CEO purchases this year" or compare it against any other ticker.
Open the AI agentVRTX insider trading FAQ
Are VERTEX PHARMACEUTICALS INC / MA insiders buying or selling?
Across 530 SEC Form 4 filings, VERTEX PHARMACEUTICALS INC / MA (VRTX) insiders reported 5 open-market purchases totaling $14.0M and 525 sales totaling $967.5M. That is a net selling position of $953.5M.
How many insiders trade VRTX stock?
26 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for VERTEX PHARMACEUTICALS INC / MA. The most recent filing was accepted on Jul 7, 2026.
Where does Trabud get VRTX insider trading data?
All VRTX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.